Trial Profile
Randomized Double Blind Placebo Controlled Cross-Over Study of Incobotulinum Toxin A (Xeomin) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Mar 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Sialorrhoea
- Focus Therapeutic Use
- Acronyms Xeomin 2012
- 27 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 27 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 27 Jul 2012 Planned end date 1 Nov 2013 added as reported by ClinicalTrials.gov. (NCT01653132).